"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Alembic Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : C R Amin
Home : Alembic Group	Book Value: 285.6722314
BSE Code : 533573	Market Cap: 15844.95
NSE Code : APLLTD	P / E : 22.73

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	1868.06	1718.74	1642.24	1796.24
Other Income	14.04	25.88	10.73	11.49
Total Income	1882.10	1744.62	1652.97	1807.73
Total Expenditure	1522.24	1469.43	1412.87	1492.93
Operating Profit	359.86	275.19	240.10	314.80
Interest	21.41	19.42	21.65	22.81
Gross Profit	338.45	255.77	218.45	291.99
Depreciation	82.54	82.31	79.67	75.64
Tax	43.34	31.84	24.31	36.99
Deferred Tax	15.61	-101.45	0.00	0.00
Reported Profit After Tax	196.96	243.07	114.47	179.36

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView